Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.64 AUD | +4.44% | +4.49% | -13.34% |
05-28 | Transcript : Neuren Pharmaceuticals Limited - Shareholder/Analyst Call | |
05-27 | Neuren Phase 2 Trial Shows Significant Improvements in Pitt Hopkins Syndrome | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEUREN PHARMACEUTICALS LIMITED | Other Pharmaceuticals | +4.44% | +4.49% | -13.34% | +52.93% | +1,681.07% | 1.83B |
- Stock Market
- Equities
- NEU Stock
- Charts Neuren Pharmaceuticals Limited
- Relative Strength Chart